Methode Electronics' Board Approves Dividend
Get Alerts MEI Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.3%
EPS Growth %: +28.6%
Join SI Premium – FREE
CHICAGO, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today that its board of directors has declared a quarterly dividend of $0.11 per share to be paid on October 25, 2019, to common stockholders of record at the close of business on October 11, 2019.
About MethodeMethode (NYSE: MEI) is a global developer of custom engineered and application specific products and solutions with manufacturing, design and testing facilities in Belgium, Canada, China, Egypt, Germany, India, Italy, Lebanon, Malta, Mexico, Singapore, Switzerland, the United Kingdom and the United States. We design, manufacture and market devices employing electrical, electronic, wireless, safety radio remote control, sensing and optical technologies to control and convey signals through sensors, interconnections and controls. Our business is managed on a segment basis, with those segments being Automotive, Interface, Industrial and Medical. Our components are in the primary end markets of the automobile, commercial vehicle, computer, information processing and networking equipment, voice and data communication systems, consumer electronics, appliances, aerospace vehicles and industrial equipment industries. Further information can be found on Methode's website www.methode.com.
For Methode Electronics, Inc. - Investor Contact:
Kristine WalczakVice President, Investor Relations and Corporate Communications[email protected]
Source: Methode Electronics, Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- QCI Celebrates Successful G2E 2026, Showcasing the Future of Unified Resort Operations
- Cancer Prevention and Screening Takes Center Stage During D.C. Summit Convened by NCCN
- EicOsis Announces Alzheimer’s Association Part the Cloud Award Supporting Phase 1b Study of EC5026 in Alzheimer's Disease
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share